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Abstract The mycotoxin deoxynivalenol (DON) contami-
nates agricultural commodities worldwide, posing health
threats to humans and animals. Associated with DON are
derivatives, such as deepoxy-deoxynivalenol (DOM-1), pro-
duced by enzymatic transformation of certain intestinal bacte-
ria, which are naturally occurring or applied as feed additives.
Using differentiated porcine intestinal epithelial cells (IPEC-
J2), we provide the first multi-parameter comparative cytotox-
icity analysis of DON and DOM-1, based on the parallel eval-
uation of lysosomal activity, total protein content, membrane
integrity, mitochondrial metabolism and ATP synthesis. The
study investigated the ability of DON and—for the first time
of its metabolite DOM-1—to induce apoptosis, mitogen-
activated protein kinase (MAPK) signalling, oxidative events
and alterations of mitochondrial structure in porcine intestinal
epithelial cells (IECs). The degree of DON toxicity strongly
varied, depending on the cytotoxicity parameter evaluated.
DON compromised viability according to the parameters of
lysosomal activity, total protein content and membrane integ-
rity, but increased viability according to assays based on mi-
tochondrial metabolism and ATP synthesis. DON induced ex-
pression of cleaved caspase-3 (maximum induction 3.9-fold)
and MAPK p38 and p42/p44 (maximum induction 2.51- and
2.30-fold, respectively). DON altered mitochondrial morphol-
ogy, but did not increase intracellular ROS. DOM-1-treated
IPEC-J2 remained unaffected at equimolar concentrations in
all assays, thereby confirming the safety of feed additives
using DON- to DOM-1-transforming bacteria. The study ad-
ditionally highlights that an extensive multi-parameter analy-
sis significantly contributes to the quality of in vitro data.
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Introduction
Mycotoxins are fungal secondary metabolites, which contam-
inate up to approximately 70% of all agricultural commodities
(Streit et al. 2012). The fusariotoxin deoxynivalenol (DON) is
one of the most prevalent of such food- and feed-associated
contaminants (EFSA 2013; Rotter et al. 1996). Its toxicity
depends primarily on species-specific susceptibility, as well
as on severity and duration of exposure. Acute DON exposure
in pigs can trigger diarrhoea, emesis, leucocytosis, haemor-
rhage, endotoxemia and, ultimately, shock-like death.
Chronic low-dose exposure may result in growth retardation
and immunological impairments (Pestka 2010a, b; Rotter
et al. 1996). Especially pigs, whose diet is largely composed
of cereal-rich feed, exhibit high DON susceptibility (Prelusky
et al. 1994).
Associated with the occurrence of DON are also its deriv-
atives, including those formed by fungi (3- and 15-acetyl-
DON), plants (3-O-glucoside-DON), animals (DON-3- and
DON-15-glucuronide and DON-sulphonates) or bacteria
(deepoxy-deoxynivalenol; DOM-1) (Berthiller et al. 2013;
Karlovsky 2011; Nagl and Schatzmayr 2015; Schwartz-
Zimmermann et al. 2014). Polygastric animals and birds have
high bacterial content located towards the beginning of the
gastrointestinal tract. This allows at least partial conversion
of DON to DOM-1 prior to reaching the small intestine, where
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absorption of the mycotoxin takes place (Maresca 2013).
Nevertheless, relevance of DOM-1 in monogastric animals,
where bacterial transformation of DON to DOM-1 is unlikely
to occur prior to reaching the small intestine, arises due to the
use of a feed additive, containing DON- to DOM-1-
transforming bacteria (EC 2013a).
The cytotoxic nature of DON, as such, has been confirmed.
It is widely assumed that, from a molecular point of view,
DON toxicology is based on the interaction of its 12–13 ep-
oxide moiety with the A-site of the eukaryotic 60S ribosomal
subunit, generating so-called ribotoxic stress (Garreau de
Loubresse et al. 2014; Pestka 2010a; Pierron et al. 2016).
However, the numerous in vitro studies dealing with cytotoxic
effects of DON report strikingly different cytotoxic potentials
of this mycotoxin (Cheli et al. 2014; Gutleb et al. 2002). This
is not only due to the use of diverse cells and cell lines but also
results from the variety of in vitro assays available for evalu-
ation of cytotoxicity. These include the neutral red (NR), the
sulforhodamine B (SRB), the lactate dehydrogenase (LDH)
and the colorimetric 3-(4,5 dimethylthiazol-2-yl)-2,5-diphe-
nyltetrazolium bromide (MTT) assay, measuring lysosomal
activity, total protein content, membrane integrity and meta-
bolic activity, respectively. Nevertheless, despite their limita-
tions, in vitro tests provide a reproducible microenvironment
for assessing mycotoxin toxicity, modes of action and biolog-
ical functions. They therefore present a suitable alternative or
prerequisite to subsequent in vivo animal testing (Cheli et al.
2014).With direct regard to mycotoxins, it has been highlight-
ed that the establishment of reliable in vitro toxicity data must
be ensured by considering not only specificity and sensitivity
of the cell line, culture conditions and the cell culture system
itself but also the cellular endpoint parameters being measured
(Gutleb et al. 2002). Considering that many studies are based
on a single cytotoxicity parameter to identify a suitable non-
cytotoxic DON concentration for implementation in further
experiments, awareness of potential assay-dependent devia-
tions of toxicity results is crucial.
Due to the oral route of DON exposure and the fact that
IECs are confrontedwith highmycotoxin concentrations upon
consumption of contaminated food or feed (Bouhet and
Oswald 2005; Bracarense et al. 2012), the present study ex-
amines the effect of DON on viability and function of cells
forming this organ system. In contrast to cancer cell lines,
IPEC-J2 (Berschneider 1989) are neither transformed nor
tumourigenic and exhibit strongmorphological and functional
resemblance of IECs in vivo (Schierack et al. 2006).
Thus, this study provides an analysis of the toxicological
profile of DON and its metabolite DOM-1, thereby extending
current knowledge regarding toxicological effects of both
compounds and confirming the safety of DON- to DOM-1-
transforming feed additives. It presents the first in vitro com-
parison of DON and its metabolite DOM-1, considering—in
parallel—six different cytotoxicity parameters, which were
further substantiated by investigation of more specific cellular
events, such as apoptosis, MAPK signalling and impact on
morphological integrity of mitochondria. Especially the com-
parative analysis of cytotoxicity highlights the considerable
dependence of in vitro cytotoxicity data on the chosen assay.
Materials and methods
Cell culture
The porcine intestinal epithelial cells IPEC-J2 (ACC701;
Leibniz Ins t i tu te DSMZ (German Col lec t ion of
Microorganisms and Cell Cultures, Braunschweig,
Germany)) were routinely cultured as previously described
(Springler et al. 2016). Cells were used up to passage 15.
For cytotoxicity and oxidative stress assays, cells were seeded
at 3 × 104 in 96-well plates (Eppendorf, Hamburg, Germany).
For total protein extraction, cells were seeded at 6 × 104 cells/
well in 12-well plates (Eppendorf, Hamburg, Germany). For
immunoblotting and mitochondrial staining, cells were seeded
in six-well plates (Eppendorf, Hamburg, Germany) or cham-
ber slides (ibidi, Martinsried, Germany), respectively, at
1 × 105 cells/well. For all assays, cells were allowed to differ-
entiate for 8 days prior to treatment.
Preparation of DON and DOM-1 stock solutions
DON (Biopure, Romer Labs®, Tulln, Austria) was dissolved
in sterile distilled water to a concentration of 6.75 mM, which
was further diluted to required concentrations in an assay-
specific diluent. DOM-1 (Biopure, Romer Labs®, Tulln,
Austria) was obtained as liquid calibrant solution
(180.15 μM in acetonitrile). Required volumes were evapo-
rated to dryness under nitrogen gas and re-dissolved in appro-
priate volumes of complete cultivation medium or Hank’s
balanced salt solution (HBSS) (Sigma-Aldrich, St. Louis,
MO, USA).
Cytotoxicity
IPEC-J2 viability was assessed on the basis of lysosomal func-
tion (NR assay), total protein content (SRB assay), cell mem-
brane integrity (LDH assay), metabolic activity (MTT and
1((4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-
1,3-benzene disulfonate (WST-1) assay) and intracellular ATP
concentration (CellTiter-Glo® (CTG) assay). Following dif-
ferentiation, cells were treated with either complete cultivation
medium (cell control), DON or DOM-1 (both 5–100 μM in
complete cultivation medium) for 24, 48 and 72 h. All assays
were performed in triplicates and in four independent experi-
ments. Optical densities (ODs) or luminescence signals were
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measured using a microplate reader (BioTek Instruments Inc.,
Winooski, VT, USA).
NR, SRB and LDH assay
DON, DOM-1 and control treatments were removed, and the
NR and SRB assays (both Aniara,West Chester, OH, USA) as
well as the LDH assay (Pierce LDH Cytotoxicity Assay Kit,
Thermo Scientific Inc., Waltham, MA, USA) were conducted
according to the manufacturer’s specifications as previously
described (Springler et al. 2016).
WST-1 and MTT assay
For the WST-1 assay (Roche, Rotkreuz, Switzerland), treat-
ments were removed and cells were incubated with a 10%
WST-1 solution in complete cultivation medium for 2 h at
39 °C. Formation of formazan dye was quantified at
450 nm, with a reference filter of 690 nm. For the MTT assay
(Molecular Probes, Life Technologies, Carlsbad, CA, USA),
treatments were removed and replaced by 100 μl HBSS.
Subsequently, cells were incubated with 12 mM MTT for
4 h. Crystalline formazan was dissolved in 50 μl dimethyl
sulfoxide (DMSO) (Sigma-Aldrich, St. Louis, MO, USA)
for 10 min at 39 °C while shaking. OD was measured at
570 nm.
CellTiter-Glo® assay
Untreated and DON- or DOM-1-treated cells were equilibrat-
ed to room temperature for 30 min. According to the manu-
facturer’s instructions, CellTiter-Glo® Reagent (CellTiter-
Glo® Luminescent Cell Viability Assay, Promega,
Fitchburg,WI, USA)was added to each well in volumes equal
to the amount of the cell culture medium. The plate was shak-
en for 2 min and subsequently incubated for 10 min at room
temperature before luminescence was measured (integration
time 1 s).
Total protein extraction and quantification
Following differentiation, cells were incubated with complete
cultivation medium (cell control) or DON (5–100 μM) in
complete cultivation medium for 24, 48 and 72 h. For protein
extraction, cells were washed twice with ice-cold phosphate-
buffered saline (PBS) (Sigma-Aldrich, St. Louis, MO, USA),
incubated with radioimmunoprecipitation assay (RIPA) buffer
(Sigma-Aldrich, St. Louis, MO, USA) supplemented with 1×
cOmplete™, Mini Protease Inhibitor Cocktail (Roche,
Rotkreuz, Switzerland) for 5 min on ice, harvested by scraping
and transferred to microcentrifuge tubes for 30 min on ice.
Cells were centrifuged (10,000×g, 30 min, 4 °C) and super-
natants collected. Protein concentration was determined via
the bicinchoninic acid (BCA) assay (Thermo Fisher
Scientific, Waltham, MA, USA) and a bovine serum albumin
(BSA) standard curve.
SDS-PAGE and immunoblotting
Immunoblot assays were performed to examine the expres-
sion of cleaved caspase-3 or MAPK activity. For cleaved
caspase-3, cells were then treated with complete cultivation
medium (cell control), DON (5–100 μM) or DOM-1
(100 μM), diluted in complete cultivation medium, for 24 h.
For MAPK activity, complete cultivation medium was re-
placed by Dulbecco’s modified Eagle’s medium without sup-
plements during the final 24 h of differentiation, to avoid high
basal MAPK activation due to media components.
Subsequently, cells were treated with Dulbecco’s modified
Eagle’s medium (no supplements) (cell control), DON (10–
30 μM) or DOM-1 (100 μM), diluted in Dulbecco’s modified
Eagle’s medium (no supplements) for 1 h. Protein extraction
and determination of protein concentration (BCA assay) was
determined as described above.
Samples (20 μg) were loaded on sodium dodecyl sulphate
(SDS) polyacrylamide gel in parallel with the prestained lad-
der (SM1811, 10–250 kD; Thermo Fisher Scientific,
Waltham, MA, USA) and subsequently transferred onto a
PVDF membrane by semi-dry electroblotting for 50 min.
Membranes were blocked in 5% w/v skimmed milk power
(Sigma-Aldrich, St. Louis, MO, USA), 1× Tris-buffered saline
(TBS) and 0.1% Tween® 20 (Sigma-Aldrich, St. Louis, MO,
USA) for 1.5 h at room temperature. For assessment of apo-
ptosis, membranes were incubated with anti-rabbit cleaved
caspase-3 (Asp175) (5A1E) rabbit monoclonal antibody
(1:1,000; Cell Signalling, Danvers, MA) in 5% w/v BSA, 1×
TBS and 0.1% Tween® 20 overnight at 4 °C with gentle
shaking. For examination ofMAPK activity, membranes were
probed with rabbit anti-phospho-p44/42 ERK MAPK
(1:1,000), rabbit anti-endogenous-p44/42 ERK MAPK
(1:1,000), rabbit anti-phospho-p38 MAPK (Thr180/Tyr182)
(3D7) and rabbit anti-endogenous-p38 (1:1,000) (all Cell
Signalling, Danvers, MA) in 5% w/v BSA, 1× TBS and
0.1% Tween® 20 overnight (4 °C while gently shaking). In
all experiments, detection of ß-actin with (13E5) rabbit mono-
clonal antibody (1:2,000; Cell Signalling, Danvers, MA) was
used as internal loading control. Following incubation, mem-
branes were washed and incubated with alkaline phosphatase-
labelled goat anti-rabbit IgG (Sigma-Aldrich, St. Louis, MO,
USA) for 1.5 h at room temperature with gentle shaking. After
washing, blots were developed in substrate buffer (100 mM
Tris, pH 9.5, 100 mM NaCl, 5 mM MgCl2) supplemented
with 5-bromo-4-chloro-3-indolyl phosphate disodium salt
(BCIP) and nitroblue tetrazolium chloride (NBT) (both
Thermo Fisher Scientific, Waltham, MA, USA). Membranes
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were analysed using myImageAnalysis™ Software (Thermo
Fisher Scientific, Waltham, MA, USA).
Oxidative stress
Ratio reduced glutathione to oxidized glutathione
Total glutathione (GSH + GSSG) and oxidized glutathione
(GSSG) of DON- and DOM-1 (both 5–100 μM)-treated cells
(GSH/GSSG-Glo™ Assay, Promega, Fitchburg, WI, USA)
were determined. For this, differentiated IPEC-J2 were treated
with provided assay buffer (cell control), DON or DOM-1
(both 5–100 μM) or with positive control H2O2 (1 mM)
(Sigma-Aldrich, St. Louis, MO, USA) (all diluted in provided
assay buffer) for 45 min at 39 °C and 5% CO2. Subsequently,
treatments were removed and replaced with either total gluta-
thione lysis reagent or oxidized glutathione lysis reagent.
Finally, luciferin lysis reagent was added to all wells for
30 min, followed by luciferin detection reagent for 15 min.
Luminescence was read, and GSH/GSSG ratios were calcu-
lated directly from relative luminescence unit (RLU) measure-
ments. The GSSG reaction signal was subtracted from that of
the total glutathione signal to yield the value of reduced glu-
tathione in the sample. For determining intracellular oxidative
stress of DON and DOM-1, the 2′,7′-dichlorofluorescein
diacetate (DCFH) (Sigma-Aldrich, St. Louis, MO, USA) as-
say was performed. Following differentiation, cells were
washed with HBSS and subsequently exposed to 40 μM
DCFH in HBSS for 1 h at 39 °C and 5% CO2. Cells were then
washed with HBSS and treated with HBSS (cell control),
DON (5–100 μM) or DOM-1 (100 μM). Fluorescence was
measured after 1, 4, 6 and 24 h using excitation and emission
wavelengths of 480 and 530 nm, respectively.
Confocal laser scanning microscopy
Following differentiation, IPEC-J2 were treated with DON
(30–100 μM) for 24 h and subsequently incubated with
25 nM MitoTracker Deep Red 633 (Life Technologies,
Carlsbad, CA, USA) for 30 min, fixed with 3.7% formalde-
hyde in PBS and counterstained with 150 nM 4′,6-diamidino-
2-phenylindole (DAPI) (Life Technologies, Carlsbad, CA,
USA) in PBS. Images were captured using a laser scanning
confocal microscope (Leica SP5 II, Wetzlar, Germany).
Statistics
Statistical analysis was performed with IBM® SPSS Statistics
19.0 (SPSS Inc., Chicago, IL, USA). Values of each indepen-
dent experiment were expressed as means of triplicates ± stan-
dard deviation (SD). All values were analysed for normality
(Shapiro-Wilk) as well as homogeneity of variance (Levene
statistics). Normally distributed homogenous data were
analysed by analysis of variance (ANOVA) and the
Dunnett’s t test compared to the control (DON: NR, SRB data
after 24 and 48 h, LDH, WST, MTT data after 24 and 48 h,
CTG data after 24 and 72 h; GSH/GSSG; DCFH data after
24 h; apoptosis; DOM-1: all cytotoxicity assays, GSH/GSSG,
DCFH data after 24 h, apoptosis). If data were normally dis-
tributed but not homogenous, ANOVA and the Dunnett’s T3
test (DON: MTT data after 72 h, CTG data after 48 h, SRB
after 72 h, DCFH data after 1, 4 and 6 h; DOM-1: DCFH data
after 1, 4 and 6 h) or the Tamhane T2 test (DON and DOM-1:
p38 and p44/42 activation) was used. If normal distribution
was violated, the Kruskal-Wallis test was used (BCA).
Significances were marked with asterisks (*p < 0.05,
**p < 0.01 and p*** < 0.001). IC50 values were calculated
using GraphPad Prism 5.0 (GraphPad Software, Inc. La
Jolla, CA, USA).
Results
Lysosomal activity (NR assay)
Compared to the control at respective time points, 100 μM
DON reduced viability by a maximum of 58% (p < 0.001)
after 24 h, 86% (p < 0.001) after 48 h and 95% (p < 0.001)
after 72 h (Fig. 1a). IC50 values were determined after 48 h
(IC50 44.83 ± 6.14 μM) and 72 h (IC50 25.93 ± 5.13 μM) of
DON treatment. DOM-1 did not negatively affect viability of
IPEC-J2 at any tested concentration (Fig. 1b).
Total protein content (SRB and BCA assay)
Compared to the control at respective time points, 100 μM
DON decreased viability by a maximum of 77% (p < 0.001)
after 24 h, 91% (p < 0.001) after 48 h and 97% (p = 0.017) after
72 h (Fig. 1c). IC50 values were determined after 24 h (IC50
35.97 ± 11.85 μM), 48 h (IC50 18.90 ± 5.70 μM) and 72 h
(IC50 2.47 ± 1.94 μM). Equimolar amounts of DOM-1 (5–
100 μM) did not reduce IPEC-J2 viability (Fig. 1d).
According to the BCA assay, 100 μM DON decreased protein
content by approximately 54% (24 h), 70% (48 h) and 87%
(72 h) (Fig. 2).
Membrane integrity (LDH assay)
No significant LDH release was detected after the 24-h DON
(5–60 μM) treatment. Only at 100 μM were LDH levels sig-
nificantly higher than that of the control, reaching 0.93 ± 0.20
(p = 0.015) compared to the control (0.44 ± 0.24) (+111%).
After 48 h, significant LDH increases were observed at 10–
100 μM and after 72 h between 5 and 100 μMDON (Fig. 1e).
DOM-1 did not induce LDH release exceeding that of the
control at any tested concentration (Fig. 1f).
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Fig. 1 DON differentially affected viability of IPEC-J2 while DOM-1-
treated cells remained unaffected. Differentiated IPEC-J2 were treated
with DON or DOM-1 (5–100 μM) for 24, 48 and 72 h. Cytotoxicity
was evaluated based on lysosomal function (NR) (a, b), total protein
content (SRB) (c, d), membrane integrity (LDH) (e, f), metabolic
activity of mitochondria (WST-1 (g, h) and MTT (i, j)) and ATP
synthesis (CTG) (k, l). Data represent mean ± SD, n = 4. The dataset
was analysed via the Dunnett’s t test or the Dunnett’s T3 test (for details
see the BMaterials and methods^ section). Asterisks indicate significant
difference compared to control of the respective time point (*p < 0.05;
**p < 0.01; and ***p < 0.001)
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Metabolic activity (WST-1 and MTTassay)
According to the WST-1 assay, DON did not decrease viabil-
ity at any test concentration after 24 h. At 10 μM DON, via-
bility was even significantly increased by approximately 25%
(p = 0.049) compared to the control. At 100 μM, viability
reached control levels. After 48 h, OD was approximately
equal to the control between 5 and 30 μM and below the
control at higher concentrations. At 100 μM, viability was
significantly decreased by 61% (p = 0.001) compared to the
control. Only after 72 h, DON (5–100 μM) significantly re-
duced viability, with a maximum reduction of 79% (p < 0.001)
at 100 μM (Fig. 1g).
The MTT assay showed no significant DON-induced via-
bility reduction; however, particularly high standard devia-
tions were observed. Viability did not fall below that of the
control at any DON concentration after 24 and 48 h. Only at
100 μM was DON viability below that of the respective con-
trol at 72 h (Fig. 1i). In contrast to the effects induced byDON,
DOM-1 did not affect cell viability at any test concentration
(Fig. 1h, j).
Intracellular ATP (CTG assay)
According to the CTG assay, luminescence significantly
exceeded control levels at all test concentrations after 24 h
and between 5 and 30 μM after 48 h. Luminescence reached
maxima at 10 μM (+49%, p < 0.001) and at 20 μM (+51.8%,
p = 0.002), respectively. After 72 h, luminescence was signif-
icantly higher than that of the cell control only at 10 μM
(+48%, p = 0.023). At remaining test concentrations, no sta-
tistically significant effect was observed. However, viability
was above that of untreated control cells up to 60 μM DON
(Fig. 1k). DOM-1 had no effect on cellular metabolism or
intracellular ATP (Fig. 1l).
Apoptosis
DON significantly induced caspase-3 activation by a factor of
2.82 ± 0.53 at 5 μM (p < 0.001) and 3.36 ± 0.51 at 10 μM
(p < 0.001) compared to the control. Between 30 and
100 μMDON, expression of cleaved caspase-3 was increased
by a factor of 3.7–3.9 compared to the control (p < 0.001 for
all DON concentrations). In comparison, DOM-1 (100 μM)
did not induce expression of active cleaved caspase-3 in dif-
ferentiated IPEC-J2. The protein expression of the housekeep-
ing protein ß-actin remained stable under all concentrations
(Fig. 3a, b).
Effect of DON and DOM-1 on phosphorylation status
of MAPK protein p38 and p44/p42
While DOM-1 (10–30 μM) did not affect the phosphorylation
status of p38 or p44/p42, DON treatment (10–30 μM) indi-
rectly induced phosphorylation of p38 and p44/42. At 10 and
30 μM, phosphorylated p38 was increased by a factor of 2.37
± 0.37 (p = 0.031) and 2.51 ± 0.29 (p = 0.011), respectively.
DON increased levels of phosphorylated p44/42 (ERK1/2)
at 10 μM (1.79 ± 0.19 (p = 0.024)) and 30 μM (2.30 ± 0.22
(p = 0.008)). The expression of the housekeeping protein ß-
actin remained stable under all conditions (Fig. 4a, b).
Effect of DON and DOM-1 on oxidation level
of differentiated IPEC-J2
Although the GSH/GSSG ratio was slightly below (−14% at
100 μM) the control, no statistically significant DON-induced
reduction of the GSH/GSSG ratio was observed. In contrast,
1 mMH2O2 (positive control) decreased the GSH/GSSG ratio
significantly by 43%, from 31.00 in untreated control cells to
17.52 (p = 0.001) (Table 1). DOM-1 did not decrease the
GSH/GSSG ratio at any concentration. At 5 μM DOM-1,
the GSH/GSSG ratio equalled 42.2 compared to the control
(32.80). At 50 and 100 μM DOM-1, the ratio of GSH to
GSSG was approximately at the level of control cells
(Table 1). According to the DCFH assay, neither DON (5–
100 μM) nor DOM-1 (100 μM) led to significant reactive
oxygen species (ROS) generation over 24 h (Fig. 5).
Effect of DON on mitochondrial morphology
Mitochondria in control cells stained with the fluorophore
MitoTracker® Deep Red FM revealed thin, filamentous struc-
tures under a confocal laser microscope, similar to those pre-
viously reported in literature (Johnson et al. 1980; Karbowski
et al. 1999b; Poot et al. 1996). However, mitochondria of cells
Fig. 2 DON reduced total protein content. Differentiated IPEC-J2 were
treated with DON (5–100 μM) for 24, 48 and 72 h. Total protein was
extracted and quantified via the BCA assay. Data was normalized to
control and represent mean ± SD, n = 4. The dataset was analysed via
the Kruskal-Wallis test (for details see the BMaterials and methods^
section). Asterisks indicate significant difference compared to control of
the respective time point (*p < 0.05; **p < 0.01; and ***p < 0.001)
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Fig. 3 DON, but not DOM-1,
induced caspase-3 activation.
Differentiated IPEC-J2 were
treated with DON (5–100 μM) or
DOM-1 (100 μM) for 24 h. The
expression of apoptosis indicator
cleaved caspase-3 was analysed
by immunoblotting (a) and by
densitometry after normalization
with ß-actin signals (b). Data was
normalized to control and
represent mean ± SD, n = 4. The
dataset was analysed via Dunnet’s
test (for details, see the BMaterials




Fig. 4 DON, but not DOM-1,
induced MAPK protein p38 and
p44/p42 activation. Differentiated
IPEC-J2 were treated with DON
(10–30 μM) or alternatively
DOM-1 (100 μM) for 1 h. The
phosphorylation status of p44/p42
and p38 was determined by
immunoblotting (a) and by
densitometry after normalization
with endogenous signals and ß-
actin (b). Data was normalized to
control and represent mean ± SD,
n = 4. The dataset was analysed
via the Tamhane T2 test (for
details, see the BMaterials and
methods^ section). Asterisks
indicate significant difference
compared to control (*p < 0.05;
**p < 0.01)
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treated with DON for 24 h led to a varied population of fila-
mentous and granular structures. With increasing DON con-
centrations, mitochondria became predominantly granular,
thicker and more condensed and located mainly in the vicinity
of the nucleus. Furthermore, a slight increase in the nucleus
size is observed with increasing concentrations of DON
(Fig. 6).
Discussion
In vitro cytotoxicity assays facilitate the detection of many
mycotoxins, which potentially impair the biochemical ac-
tivity of animal or human cells. The present study provides
the first comparative in vitro analysis of DON and DOM-1
in porcine IECs, based on six cytotoxicity parameters.
While we were able to confirm previous reports regarding
the lack of DOM-1 toxicity, we demonstrated substantial
variations with regard to DON cytotoxicity, depending on
the employed assay type. Many existing in vitro DON stud-
ies are restricted to a single cytotoxicity assay, such as the
MTT (Alassane-Kpembi et al. 2015; Wan et al. 2013), LDH
(Diesing et al. 2011a; Pinton et al. 2009) or NR (Devreese
et al. 2013; Vandenbroucke et al. 2011) assay. Their com-
parison reveals remarkable differences with respect to the
degree of cytotoxicity, even for identical cell lines. In agree-
ment with Cheli et al. (2014), we herein demonstrate that the
inclusion of several toxicity-associated endpoints greatly
Fig. 5 Neither DON, nor DOM-1, increased intracellular ROS
concentrations. Differentiated IPEC-J2 were exposed to 2′,7′-
dichlorofluorescein diacetate (DCFH) (40 μM) for 1 h and
subsequently treated with DON (5–100 μM), DOM-1 (100 μM) or
positive control H2O2 (1 mM) for 1, 4, 6 and 24 h. Data is presented as
relative fluorescence units (RFU) and was normalized to negative control
(untreated cells). The dataset was analysed via Dunnett’s t test or
Dunnett’s T3 test (for details, see the BMaterials and methods^ section).
Data represent mean ± SD, n = 4. Asterisks indicate significant difference
compared to control (**p < 0.01 and ***p < 0.001)
Table 1 Neither DON, nor DOM-1, altered ratio of oxidized to reduced glutathione (GSH/GSSG)
Total glutathione (GSH + GSSG) Oxidized glutathione (GSSG) Reduced/oxidized glutathione (GSH/GSSG)
mM H2O2 H2O2 H2O2
1 1.97 × 106 ± 1.76 × 104 2.02 × 105 ± 6.88 × 103 17.52 ± 0.54* (p = 0.001)
μM DON DOM-1 DON DOM-1 DON DOM-1
0 1.7 × 106 ± 1.9 × 105 1.7 × 106 ± 2.3 × 105 1.1 × 105 ± 1.7 × 104 9.9 × 104 ± 1.1 × 104 31.0 ± 5.6 32.8 ± 5.3
5 1.8 × 106 ± 2. 0 × 105 1.4 × 106 ± 7.8 × 104 1.2 × 105 ± 2.5 × 104 6.3 × 104 ± 6.4 × 103 27.3 ± 5.0 42.2 ± 7.4
50 1.8 × 106 ± 1.8 × 105 1.5 × 106 ± 8.0 × 104 1.3 × 105 ± 2.7 × 105 8.1 × 105 ± 1.3 × 104 27.0 ± 5.2 34.5 ± 3.9
100 1.8 × 106 ± 9.3 × 105 1.5 × 106 ± 1.0 × 105 1.3 × 105 ± 2.9 × 105 8.5 × 104 ± 9.9 × 103 27.2 ± 6.7 34.0 ± 4.5
Differentiated IPEC-J2 were treated with DON (5–100 μM) (n = 4), DOM-1 (5–100 μM) or positive control H2O2 (1 mM) (both n = 3) for 45min. Total
and oxidized glutathione were determined via the GSH/GSSG-Glo™ assay. The dataset was analysed via Dunnett’s t test (for details, see the BMaterials
and methods^ section). Data represent mean ± SD. Asterisks indicate significant difference compared to control
*p < 0.01
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improves the predictive power of in vitro tests, not just for
mycotoxins, but for toxicants in general.
The presented in vitro analysis included DON concentra-
tions between 5 and 100 μM. For the applied cell culture
model, which does not discriminate between apical and
basolateral compartments, the range of 5–30μMDON, equiv-
alent to food and feed contaminations of 1.5 to 10 mg/kg
(Sergent et al. 2006), is particularly relevant. This not only
corresponds to concentrations present in feed (Abouzied
et al. 1991; Trucksess et al. 1995); it is also a concentration
range which, when applied apically, negatively affects param-
eters such as intestinal barrier integrity (Pinton et al. 2009,
2010; Springler et al. 2016). In the case of basolateral exposi-
tion of IECs to DON, resembling in vivo contact to DON via
the bloodstream, relevant concentrations are expected to be far
lower (Danicke et al. 2004).
Fig. 6 DON structurally altered
the filamentous mitochondrial
network and promotes
granularization in vicinity of the
nucleus. Differentiated IPEC-J2
were left untreated (control) or
were exposed to DON (30–
100 μM) for 24 h. Subsequently,
cells were stained with
MitoTracker Deep Red FM
(25 nM), fixed with formaldehyde
and counterstained with 4′,6-
diamidino-2-phenylindole
(DAPI) (150 nM). Scale bar
50 μm
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Strongest DON toxicity was reflected by the SRB, follow-
ed by the NR and LDH assays. This is particularly well illus-
trated after 24 and 48 h, where sensitivities to the toxin varied
greatly between the three assays. Although we are the first to
study DON-induced toxicity via SRB incorporation, Kluess
et al. (2015) reported a 25% reduction of total protein content
via western blotting in differentiated IPEC-J2 treated with
6.75 μM DON for 72 h. In contrast, we report reductions of
50 and 70% (SRB) and 16 and 43% (BCA) at 5 and 10 μM
DON after 72 h, respectively. Nevertheless, the severe effect is
in accordance with the primary toxicological feature of DON,
namely its impairment of protein synthesis (Van deWalle et al.
2010). Although neither the SRB nor the BCA assay monitor
de novo protein synthesis, the observed effect on protein con-
tent may—at least partially—be a downstream effect of DON-
induced impairment of protein synthesis. With regard to the
NR assay, a study on 21-day differentiated IPEC-J2 showed
that 5 μg/ml (∼17 μM) and 10 μg/ml (∼33 μM) DON, when
applied for 24 h, decreased IPEC-J2 viability by∼15 and 20%,
respectively (Vandenbroucke et al. 2011). Our analysis re-
vealed comparable viability reductions of 15% at 20 μM and
18% at 30 μM DON.
Compared to the SRB and NR assay, the LDH assay
showed far less severe DON toxicity. LDH leakage is not
strictly a result of membrane damaging effects but can be a
downstream event of apoptosis and subsequent secondary ne-
crosis, where cytosolic components, such as LDH, leak to the
cell exterior. Thus, detection of LDH in the supernatant does
not permit discrimination between primary necrosis and sec-
ondary necrosis as a consequence of apoptotic cell death. The
induction of cleaved caspase-3 and the absence of LDH in cell
culture supernatant observed after 24 h however suggest that
the observed LDH release after 48 and 72 h was a result of
secondary necrosis of apoptotic cells. It should be noted that
the faint band, indicating cleaved caspase-3 expression, in
control cells most likely results from the presence of fetal
bovine serum in the cultivation medium. Furthermore, we
recognize the lack of a positive control (e.g. staurosporine)
for detection of apoptosis.
The observed DON-induced apoptosis is likely to be a
downstream effect of early p38 activation (Wu et al. 2014),
which we detected after 1 h. DON most likely induced signal-
ling cascades, which then led to p38 phosphorylation, a stress
response to DON. A similar finding was made in macro-
phages, were p38 activation was detected at high DON doses
(μM) (Pestka 2010a, c). The observed p44/p42 activation in
DON-treated cells may be interpreted as a general cellular
response to DON, possibly linked to the activation of cellular
repair mechanisms. Additionally, MAPK p44/42 is involved
in IEC morphology and tight junction signalling, which are
negatively affected by DON (Pinton et al. 2009). DON-
induced p44/42 activation has also been reported in porcine
IECs of the ileum and jejunum (IPEC-1) (Pinton et al. 2010),
mouse spleen (Zhou et al. 2003) and porcine dendritic cells
(Sergent et al. 2006).
In contrast to the SRB, NR and LDH assays, the MTT,
WST-1 and CTG assays delivered unusually high viability
signals, often at the level of or exceeding the cell control.
Despite limitations (lack of sensitivity, chemical interferences)
and toxicity of the MTT compound (Riss et al. 2004), the
MTT assay is commonly used to determine DON toxicity.
While we found no DON-induced viability reductions via
the MTTassay, Wan et al. (2013) reported viability reductions
to 85 and 58% after 48 h in differentiated IPEC-J2 treated with
1 or 2 μM DON, respectively. Others found significant via-
bility reductions of differentiated IPEC-J2 at 1000–4000 ng/
DON (∼3.4–13.5μM) after 48 and 72 h (Diesing et al. 2011b).
Nevertheless, our finding is supported by a recent study,
reporting an underestimation of the anti-proliferative effect
of (−)-epigallocatechin-3-gallate (EGCG) via the MTT assay.
While ATP- and DNA-based methods revealed anti-
proliferative effects of EGCG, the MTT method indicated
EGCG-induced proliferation increases of up to 15%. The au-
thors speculate about the ability of EGCG to increase mito-
chondrial dehydrogenase activity and its potential to reduce
MTT. They emphasize that metabolic activity may be influ-
enced by diverse factors, causing considerable variation of
results reported from these in vitro assays (Wang et al. 2010).
Only few studies have shown viability data of DON-treated
cells via the WST-1 assay. Vejdovszky et al. (2015) reported
significant viability decreases after a 24-h treatment of undif-
ferentiated Caco-2 with 10 μMDON. We are the first to eval-
uate DON toxicity according to the CTG assay in differenti-
ated IPEC-J2. Only Awad et al. (2012) reported significant
ATP concentration reduction after 48 h in undifferentiated
IPEC-J2 treated with 2.5–10 μM DON.
Based on the excessive viability signals detected by theWST-
1, MTTand CTG assays and due to the accumulation of reports,
connecting primary steps of apoptosis to mitochondrial alter-
ations (Cossarizza et al. 1994; Petit et al. 1995), we hypothesized
that DON may trigger mitochondrial swelling and possibly for-
mation of megamitochondria. The latter was previously reported
in HT-29 cells, treated with DON (∼1.7 μM) for 24 h
(Krishnaswamy et al. 2010). However, we are the first to exam-
ine potential DON-induced mitochondrial swelling or
megamitochondria formation in porcine IECs. The loss of the
typical thin filamentous mitochondrial network in DON-treated
IPEC-J2 and the formation of enlarged and granular-shaped mi-
tochondria located in close vicinity of the nucleus are in accor-
dance with characteristics of mitochondrial enlargement reported
in literature. While normal mitochondria are described as thin
filamentous structures (Bspaghetti^), megamitochondria are
granular, round in shape and densely packed around the nucleus
(Bmeatballs^) (Ahmad et al. 2001; Karbowski et al. 1999a).
We hypothesize that the high metabolic activity and ATP
production of DON-treated cells, as shown by theMTT,WST-
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1 and CTG assays, could—at least partially—be due to inter-
ferences of DON with mitochondrial morphology.
Mitochondrial volume homeostasis ensures structural integri-
ty of the organelle, and increased mitochondrial matrix vol-
ume activates the respiratory chain, increasing ATP produc-
tion and respiration rates (Halestrap 1987, 1989; Lim et al.
2002). It could be hypothesized that while the cell is under
energetic stress, where the need for ATP is high, an increase in
matrix volume could lead to further activation of the respira-
tory chain (Kaasik et al. 2007). In fact, a study related to the
electron transport chain activity in megamitochondria has re-
vealed a 50% increase in the activity of succinate dehydroge-
nase activity (Wagner and Rafael 1975). It has also been sug-
gested that disruption of protein synthesis could be a second-
ary factor contributing to mitochondrial enlargement
(Karbowski et al. 1997, 1999a). Consequently, DON-
induced ribotoxic stress could be a factor leading to mitochon-
drial enlargement. Although increases in ROS have been
shown to precede formation of megamitochondria, we could
not detect DON-induced oxidative stress and therefore cannot
support this hypothesis (Karbowski et al. 1999a).
Aside from the comparative analysis of DON, the present
study is particularly relevant with respect to DON metabolite,
DOM-1. The toxicological relevance of DOM-1, which has been
poorly documented, is justified by natural exposure as well as
through the frequent use of DON- to DOM-1-converting feed
additives. The amount of DONmetabolites has not been consid-
ered in the regulatory limits fixed by food agencies, due to the
lack of data regarding their absorption and toxicity (Maresca
2013). The present study included a thorough cell-based investi-
gation of DOM-1, which has not yet been performed in this
manner. Only few studies are available regarding DOM-1
in vitro cytotoxicity. Danicke et al. (2010) assessed DOM-1 cy-
totoxicity in PBMCs and differentiated IPEC-1 and IPEC-J2
over 48 h, however only via a single MTTassay, and concluded
lack of DOM-1 cytotoxicity under these conditions. Sundstol
Eriksen et al. (2004) tested the effect of DOM-1 on 3T3 fibro-
blasts via BrdU incorporation and reported the IC50 of DOM-1
to be ∼55 times higher than that of DON. Nasri et al. (2006)
assessed the effect of DOM-1 in Jurkat T cells via a single
alamarBlue assay as well as the potential of DOM-1 to induce
apoptosis or necrosis via Annexin V staining. Finally, Pierron
et al. (2016) recently demonstrated that 30 μM DOM-1 does
not affect viability of proliferating Caco-2 cells via the CTG
assay. The authors demonstrated that 10 μM DOM-1 does not
activate MAPK proteins p38 and Sapk/JNK and showed that
bacterial de-epoxidation of DON alters its interaction with the
ribosome. Accordingly, both DON and DOM-1 fit into the
pockets of the A-site of the ribosomal peptidyl transferase center.
However, while DON forms three hydrogen bonds, DOM-1
forms only two, thereby losing its ability to activate MAPK
signalling. Thus, our study is not only the first to evaluate and
exclude DOM-1 toxicity according to six cytotoxicity assays in
parallel, it is also the first to demonstrate a lack of DOM-1-
mediated apoptosis via cleaved caspase-3 activation, MAPK sig-
nalling or oxidative stress in differentiated porcine IECs.
Furthermore, we are the first to test DOM-1 up to a concentration
as high as 100 μM. We thereby extend current knowledge re-
garding the safety of feed additives containing DON- to DOM-1-
transforming bacteria.
Considering the high DON susceptibility of pigs, the non-
tumorigenic and non-transformed IPEC-J2 is a highly suitable
in vitro model (Berschneider 1989; Nossol et al. 2015) to study
the impact of DON and DOM-1. While differentiated IPEC-J2
are frequently cultured in two-compartment transwell membrane
systems, various investigations have been conducted with differ-
entiated IPEC-1 and IPEC-J2 in conventional well plates
(Broekaert et al. 2016; Diesing et al. 2011b; Vandenbroucke
et al. 2011; Wan et al. 2013). By culturing IPEC-J2 in 96-well
plates for 1 or 21 days, Vandenbroucke et al. (2011) established
that, compared to proliferating cells, differentiated porcine IECs
show a 10-fold higher DON sensitivity. Using IPEC-1 and IPEC-
J2, both cultured in conventional one-compartment plates,
Diesing et al. (2011b) monitored expression of tight junction
protein zona occludens 1 (ZO-1) and enzyme activity of alkaline
phosphatase, a marker of differentiation. By day 4, immunoflu-
orescence staining of ZO-1 revealed a continuous lining around
adjacent cells, which remained unchanged until day 21. Alkaline
phosphate enzyme activity was remarkably increased between
days 2 and 3, remaining stable until day 22. Additionally, the
authors demonstrated that in transwell membrane inserts, cells
exhibited a similar kinetic as in normal plates, reaching
transepithelial electrical resistance (TEER) values above
1 kOhm× cm2 after 4 days. Nevertheless, it should be stated that
the differentiation of IPEC-J2 in two-compartment cultivation
systems has been shown to promote optimal development of a
polarized epithelial barrier with differentiated apical and
basolateral features, thereby closely mimicking in vivo condi-
tions (Kluess et al. 2015; Nossol et al. 2010). Furthermore,
Diesing et al. (2011a) and Kluess et al. (2015) demonstrated that
IPEC-J2 react differently to DON, depending on whether the
toxin is applied apically or basolaterally in transwell membrane
inserts.
Therefore, besides novel aspects with respect to DON ef-
fects on mitochondria, we present the first comparative
in vitro analysis of DON and DOM-1, based on six different
parameters of cytotoxicity. Although frequently neglected in
literature, assays based on different cellular parameters reflect
differential responses of cellular functions and compartments.
Multi-parameter approaches, as presented in this study, permit
a reliable in vitro picture of the toxicological relevance of not
just DON or DOM-1, but of any given compound, thereby
strengthening in vitro tests as a suitable alternative or prereq-
uisite to in vivo animal testing. The study highlights the need
for meticulous evaluation of the method used for in vitro as-
sessment of cell viability to improve probabilities to detect
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toxicants, which might otherwise be underestimated or
overestimated.
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